Wei Huang

Company: Chengdu New Radiomedicine Technology

Job title: Deputy Manager

Seminars:

Preclinical Characterisation of a Novel 68Ga/177Lu-Labeled Fibroblast Activation Protein (FAP) Targeted Peptide Binder for Cancer Imaging & Therapy 3:00 pm

• NT6020 is a potent and specific novel peptide binder to FAP. • 177Lu-NT6020 demonstrates efficient and continued tumour uptake with fast renal clearance, and minimal normal tissue uptake. • 177Lu-NT6020 significantly inhibits tumour growth in FAP-expressing HEK293 xenograft model.Read more

day: Conference Day 2